SEC Form 4 · accession 0001144204-17-048963
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dean J Warras
Officer — Pres Animal Health & Nutr N.A.
Period of report
Sep 15, 2017
Accepted (ET)
Sep 20, 2017 · 9:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 15, 2017 | M | 10,000 | $11.83 | A | 10,000 | D | |
| Class A Common StockF2 | Sep 15, 2017 | S | 4,400 | $35.46 | D | 5,600 | D | |
| Class A Common StockF3 | Sep 15, 2017 | S | 5,600 | $35.89 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Class A Common Stock | $11.83 | Sep 15, 2017 | M | 10,000 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 10,000 | 11,780 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.75 to $35.70, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.75 to $35.90, inclusive.